[CLDX] YoY Annual Result on 31-Dec-2017 [#FY]

Stock
[CLDX] Celldex Therapeutics, Inc.
Announcement Date
07-Mar-2018
Financial Year
2017
Quarter
31-Dec-2017 [#FY]
Profit Trend
YoY- 27.62%
Quarter Report
CLDX's Result
CLDX's Financial Summary
View:
Show?
Annual Result
31/12/20 31/12/19 31/12/18 31/12/17 31/12/16 31/12/15 31/12/14 CAGR
Revenue 7,418 3,573 9,538 12,743 6,786 5,480 3,586 12.86%
PBT -60,947 -50,878 -151,949 -117,313 -128,530 -127,197 -118,080 -10.42%
Tax -1,167 -506 -765 -24,282 -8,772 -2,344 -4,350 -19.67%
NP -59,780 -50,372 -151,184 -93,031 -128,530 -127,197 -118,080 -10.71%
Tax Rate - - - - - - - -
Total Cost 67,198 53,945 160,722 105,774 135,316 132,677 121,666 -9.41%
Ratio Analysis
31/12/20 31/12/19 31/12/18 31/12/17 31/12/16 31/12/15 31/12/14 CAGR
NP Margin -805.88 -1,409.80 -1,585.07 -730.06 -1,894.05 -2,321.11 -3,292.81 -20.89%
Per Share
31/12/20 31/12/19 31/12/18 31/12/17 31/12/16 31/12/15 31/12/14 CAGR
EPS -2.02 -3.47 -14.48 -10.86 -18.99 -19.66 -19.81 -31.62%
EPS Diluted -2.02 -3.47 -14.48 -10.86 -18.99 -19.66 -19.81 -31.62%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.